![](/img/cover-not-exists.png)
Monoclonal anti‑MUC1 antibody with novel octahydropyrazino[2,1‑a:5,4‑a']diisoquinoline derivative as a potential multi‑targeted strategy in MCF‑7 breast cancer cells
Gornowicz, Agnieszka, Szymanowski, Wojciech, Bielawska, Anna, Szymanowska, Anna, Czarnomysy, Robert, Kałuża, Zbigniew, Bielawski, KrzysztofLanguage:
english
Journal:
Oncology Reports
DOI:
10.3892/or.2019.7256
Date:
August, 2019
File:
PDF, 1.30 MB
english, 2019